Rosemary Tannock – författare

Language as a connecting bridge between learning disability and psychiatric disorder is the unifying theme of this wide-ranging book. Particular prominence is given to attention deficit hyperactivity disorder, dyslexia and autistic disorder. Explanations for the comorbidity of psychiatric and language disorder are sought in developmental, cognitive and biological fields, the contribution of imaging modalities is considered and implications for aetiology, treatment and rehabilitation are explored. Topical issues such as syndrome definition in dyslexia, acquired memory disorder in childhood and biology-behaviour correspondence are well covered, as are a range of treatment options. A final section is devoted to outcome studies. Enlivened with case vignettes, and offering insights into the range of current thinking on language and behaviour, this book is a rich resource for professionals and advanced students concerned with child health and development, offering ideas for a unified view of language, learning and behaviour problems.

Language as a connecting bridge between learning disability and psychiatric disorder is the unifying theme of this wide-ranging book. Particular prominence is given to attention deficit hyperactivity disorder, dyslexia and autistic disorder. Explanations for the comorbidity of psychiatric and language disorder are sought in developmental, cognitive and biological fields, the contribution of imaging modalities is considered and implications for aetiology, treatment and rehabilitation are explored. Topical issues such as syndrome definition in dyslexia, acquired memory disorder in childhood and biology-behaviour correspondence are well covered, as are a range of treatment options. A final section is devoted to outcome studies. Enlivened with case vignettes, and offering insights into the range of current thinking on language and behaviour, this book is a rich resource for professionals and advanced students concerned with child health and development, offering ideas for a unified view of language, learning and behaviour problems.

In this volume there is a strong emphasis on translational science, with preclinical approaches suggesting new directions for development of new treatments.  Individual chapters describe how neuroimaging, neuroendocrine, genetic and behavioral studies use powerful research tools that are offering a completely new understanding of the factors that increase vulnerability to ADHD.  The clinical impact of co-morbid problems, especially obesity and substance misuse, are highlighted and explain what such problems can tell us about the etiology of ADHD, more generally.  Reviews of the pharmacology of established drug treatments for ADHD justify an exciting novel theory for their therapeutic actions and address questions about the effects of their long‑term use.

In this volume there is a strong emphasis on translational science, with preclinical approaches suggesting new directions for development of new treatments.  Individual chapters describe how neuroimaging, neuroendocrine, genetic and behavioral studies use powerful research tools that are offering a completely new understanding of the factors that increase vulnerability to ADHD.  The clinical impact of co-morbid problems, especially obesity and substance misuse, are highlighted and explain what such problems can tell us about the etiology of ADHD, more generally.  Reviews of the pharmacology of established drug treatments for ADHD justify an exciting novel theory for their therapeutic actions and address questions about the effects of their long‑term use.